Enabling Biogenerics: Exploiting Comparability to Limit Clinical Trial Needs by Anders Elbak List Price: $500.00 $500.00 At Amazon on 10-16-2008.

Do you have the free reader for this item? Format: Adobe Reader PDF Printable: Yes. This title is printable Mac OS Compatible: OS 9.x or later Windows Compatible: Yes Handheld Compatible: Yes. Adobe Reader is available for PalmOS, Pocket PC, and Symbian OS. Digital: 4 pages Publisher: IDC Research January 10, 2007 Product Description This Health Industry Insights Perspective describes analyst perspectives in response to recently proposed legislation to enable the approval of generic biological drugs (biogenerics) by the U.S. Food and Drug Administration (FDA). The proposed legislation aspires to provide competitive pressure to develop generic alternatives to FDA-approved biological drugs that have exhausted patent protections with the overall goal of decreasing drug costs for consumers. Enabling Biogenerics: Exploiting Comparability to Limit Clinical Trial Needs Available from Amazon Price: $500.00 Updated on 10-16-2008.

Search: All Products Books Magazines Popular Music Classical Music Video DVD Toys & Games Baby Computer & Video Games Electronics Software Tools & Hardware Outdoor Living Kitchen & Housewares Camera & Photo Wireless Phones Keywords:

NOTICE: All product prices, availability, and specifications
are subject to verification by their respective retailers.

Copyright © 2008,Dominant Systems Corporation
info@medvolumes.com         Privacy Policy
Last Modified : 10-16-2008